Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple MyelomaMichele Moschetta, Angelo Vacca, Antonio Basile et al.|Clinical Cancer Research|2013Cited by 68
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infectionDF Bavaro, Annalisa Saracino, Lucia Diella et al.|Pathogens and Global Health|2022Cited by 10
A Challenging Case of Visceral LeishmaniasisAntonio Giovanni Solimando, Angelo Vacca, Giuseppe Coniglio et al.|Reports — Medical Cases Images and Videos|2022Cited by 4
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life ApplicationRoberto Mina, Elena Zamagni, Elisabetta Antonioli et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 1
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot StudySebastiano Cicco, Angelo Vacca, Marialuisa Sveva Marozzi et al.|Medicina|2023Cited by 1